chr14-100829493-G-C

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BA1

The ENST00000429159.7(MEG3):​n.679G>C variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.936 in 152,330 control chromosomes in the GnomAD database, including 66,781 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (no stars).

Frequency

Genomes: 𝑓 0.94 ( 66758 hom., cov: 33)
Exomes 𝑓: 0.96 ( 23 hom. )

Consequence

MEG3
ENST00000429159.7 non_coding_transcript_exon

Scores

2

Clinical Significance

Benign no assertion criteria provided B:1

Conservation

PhyloP100: -1.50

Publications

9 publications found
Variant links:
Genes affected
MEG3 (HGNC:14575): (maternally expressed 3) This gene is a maternally expressed imprinted gene. Multiple alternatively spliced transcript variants have been transcribed from this gene and all of them are long non-coding RNAs (lncRNAs). This gene is expressed in many normal tissues, but its expression is lost in multiple cancer cell lines of various tissue origins. It inhibits tumor cell proliferation in vitro. It also interacts with the tumor suppressor p53, and regulates p53 target gene expression. Its deletion enhances angiogenesis in vivo. Many experimental evidences demonstrate that this gene is a lncRNA tumor suppressor. [provided by RefSeq, Mar 2012]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.99).
BP6
Variant 14-100829493-G-C is Benign according to our data. Variant chr14-100829493-G-C is described in ClinVar as Benign. ClinVar VariationId is 3059566.Status of the report is no_assertion_criteria_provided, 0 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.954 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MEG3NR_002766.2 linkn.679G>C non_coding_transcript_exon_variant Exon 3 of 7
MEG3NR_003530.2 linkn.679G>C non_coding_transcript_exon_variant Exon 3 of 9
MEG3NR_003531.3 linkn.655G>C non_coding_transcript_exon_variant Exon 3 of 8

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MEG3ENST00000429159.7 linkn.679G>C non_coding_transcript_exon_variant Exon 3 of 7 1
MEG3ENST00000451743.7 linkn.679G>C non_coding_transcript_exon_variant Exon 3 of 7 1
MEG3ENST00000521404.6 linkn.669G>C non_coding_transcript_exon_variant Exon 3 of 6 1

Frequencies

GnomAD3 genomes
AF:
0.936
AC:
142460
AN:
152162
Hom.:
66706
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.940
Gnomad AMI
AF:
0.932
Gnomad AMR
AF:
0.943
Gnomad ASJ
AF:
0.933
Gnomad EAS
AF:
0.977
Gnomad SAS
AF:
0.978
Gnomad FIN
AF:
0.943
Gnomad MID
AF:
0.955
Gnomad NFE
AF:
0.925
Gnomad OTH
AF:
0.939
GnomAD4 exome
AF:
0.960
AC:
48
AN:
50
Hom.:
23
Cov.:
0
AF XY:
1.00
AC XY:
26
AN XY:
26
show subpopulations
African (AFR)
AF:
1.00
AC:
2
AN:
2
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AF:
1.00
AC:
2
AN:
2
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AF:
1.00
AC:
2
AN:
2
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
0.952
AC:
40
AN:
42
Other (OTH)
AF:
1.00
AC:
2
AN:
2
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.425
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.936
AC:
142570
AN:
152280
Hom.:
66758
Cov.:
33
AF XY:
0.938
AC XY:
69815
AN XY:
74462
show subpopulations
African (AFR)
AF:
0.940
AC:
39060
AN:
41568
American (AMR)
AF:
0.944
AC:
14442
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.933
AC:
3239
AN:
3470
East Asian (EAS)
AF:
0.977
AC:
5039
AN:
5158
South Asian (SAS)
AF:
0.978
AC:
4713
AN:
4820
European-Finnish (FIN)
AF:
0.943
AC:
10007
AN:
10612
Middle Eastern (MID)
AF:
0.959
AC:
280
AN:
292
European-Non Finnish (NFE)
AF:
0.925
AC:
62956
AN:
68030
Other (OTH)
AF:
0.939
AC:
1984
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
479
959
1438
1918
2397
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
912
1824
2736
3648
4560
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.928
Hom.:
7629
Bravo
AF:
0.936
Asia WGS
AF:
0.979
AC:
3400
AN:
3476

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link

Submissions by phenotype

MEG3-related disorder Benign:1
Aug 12, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.99
CADD
Benign
0.56
DANN
Benign
0.39
PhyloP100
-1.5

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs941575; hg19: chr14-101295830; API